Debiopharm, H3 Pharma, Societe Generale de Financement du Quebec deal

Debiopharm purchased the portion of oncology and endocrinology company H3 it did not already own from Societe Generale for an undisclosed sum. H3 was started in 2001 as a 50-50 partnership between Deb...